Cesare Orlandi, M.D. CMO Lantheus To Retire Effective September 2

Cesare Orlandi, M.D., Chief Medical Officer, will retire from the Company on September 2, 2019. The news was announced today by Lantheus Holdings, Inc.

Dr. Orlandi will be employed by the Company in a full time capacity until his retirement date, and will continue in his role as Chief Medical Officer until his successor is appointed. The Company will commence a search to identify Dr. Orlandi’s successor.

“On behalf of the entire Lantheus team and Board of Directors, I thank Ces for his many years of dedicated service to the Company, and we look forward to working with him to continue progressing our clinical and pipeline programs while we work to identify his successor,” said Mary Anne Heino, President and Chief Executive Officer.

“My decision to retire this year has not been an easy one, but now is the right time for me to make this change personally and professionally,” said Dr. Orlandi. “I am very proud of what we have accomplished since I joined as Chief Medical Officer in 2013, and I am confident the Company will successfully carry forward the momentum we’ve created.”

WE WELCOME YOUR VIEWS

Please enter your comment!
Please enter your name here